ALEXANDRIA, Va., Sept. 29 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'GALFABI' in its latest official gazette. The trademark application with the serial number 88226699 was filed on Dec. 12, 2018.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical products and substances for the treatment of Fabry disease, none of which administered using an implantable device
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): CHIESI FARMACEUTICI S.P.A. VIA PALERMO 26/A PARMA IT ITALY 43122 9 JOINT STOCK COMPANY
Disclaimer: Curated by HT Syndication....